08:53 AM EDT, 05/11/2026 (MT Newswires) -- Bernstein maintained its market-perform rating and 25.40 euro price target for Koninklijke Philips (PHIA.AS) following the Dutch health technology company's "solid"first-quarter results.

"The print was a beat both on top-line (+30bps above consensus) and on adjusted EBITA (+9% above consensus), driven primarily by a very strong Personal Health performance,"analysts said Monday, adding that the company reaffirmed its full-year 2026 guidance.

"The company expects all business segments to grow within the guidance range, albeit Diagnosis &Treatment at the lower end and Connected Care and Personal Health both at the upper end. Furthermore, the company highlighted that, while they see an impact from cost inflation and elevated price levels in their supply chain across freight, electronic components, and plastic, their guidance takes this into account and includes mitigation actions such reducing material costs, AI-enabled cost savings, and price increases,"Bernstein added.

The research firm trimmed its adjusted EPS estimates for 2026 and 2027 to 1.57 euros and 1.74 euros, respectively, from 1.59 euros and 1.77 euros, citing the risk that cost inflation poses for the remainder of the current year.

Looking ahead, however, analysts noted that they are "more positive"over Philips'ability to achieve its mid-teens margin guidance for 2028.